Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have type 1 diabetes and on insulin treatment for at least one year prior to screening
Have an HbA1c value of 7.0% to 10.5% inclusive, at screening
Have a body mass index (BMI) of ≥25 kilograms per square meter (kg/m2) at screening
Are of stable weight for at least 90 days prior to screening and agree to not start an intensive diet or exercise program during the study
You may not be if
Have experienced two or more events requiring hospitalization due to poor glucose control (hyperglycemia or (diabetic ketoacidosis (DKA)) during the period of 180 days prior to screening and until randomization.
Have experienced one or more events of severe hypoglycemia during the period of 90 days prior to screening and until randomization.
Are currently receiving or planning to receive treatment for diabetic retinopathy and/or macular edema
Have had chronic or acute pancreatitis
Have used any weight loss drugs or alternative remedies, including herbal or nutritional supplements, within 90 days prior to screening
Clareo Health | A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
